Shimshon, Israel

Tomer Zekharya

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Compugen Ltd. Corporation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomer Zekharya. Retrieved from https://idiyas.com/inventor/tomer-zekharya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomer Zekharya: Innovator in Heparanase Research

Introduction: Tomer Zekharya is a notable inventor based in Shimshon, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of heparanase research. His work focuses on the development of splice variants of heparanase, which have important implications for diagnostics and therapeutics.

Latest Patents: Tomer Zekharya holds 1 patent related to his invention of heparanase splice variants. This patent encompasses diagnostic kits, methods of use, and therapeutic agents based on these splice variants, as well as antibodies that specifically bind to them.

Career Highlights: Tomer Zekharya is associated with Compugen Ltd., a corporation that specializes in innovative drug discovery and development. His role at Compugen has allowed him to work on cutting-edge research that aims to address significant medical challenges.

Collaborations: Throughout his career, Tomer has collaborated with talented individuals such as Ronen Shemesh and Michal Ayalon-Soffer. These collaborations have contributed to the advancement of his research and the development of new therapeutic strategies.

Conclusion: Tomer Zekharya's work in the field of heparanase research exemplifies the impact of innovative thinking in biotechnology. His contributions continue to pave the way for advancements in diagnostics and therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…